NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-007-2015-0-TR-34 CD47-targeted Therapies For The Treatment Of Infectious Disease TR EP 17194591.8 Issued
NIAID E-007-2015-0-SE-33 CD47-targeted Therapies For The Treatment Of Infectious Disease SE EP 17194591.8 Issued
NIAID E-007-2015-0-ES-23 CD47-targeted Therapies For The Treatment Of Infectious Disease ES EP 17194591.8 Issued
NIAID E-007-2015-0-HR-27 CD47-targeted Therapies For The Treatment Of Infectious Disease HR EP 17194591.8 Issued
NIAID E-007-2015-0-AT-18 CD47-targeted Therapies For The Treatment Of Infectious Disease AT EP 17194591.8 Issued
NIAID E-007-2015-0-BE-19 CD47-targeted Therapies For The Treatment Of Infectious Disease BE EP 17194591.8 Issued
NIAID E-145-2011-0-US-12 PLASMODIAL SURFACE ANION CHANNEL INHIBITORS FOR THE TREATMENT OR PREVENTION OF MALARIA US DIV 15/723,677 10265313 Issued PDF
NIBIB E-150-2016-1-PCT-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS PCT PCT COMB PCT/US2017/054863 Expired
NIAID E-279-2016-1-PCT-01 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE PCT PCT COMB PCT/US2017/054959 Expired
NIAID E-279-2016-1-EP-10 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE EP DIV 22150234.7 Pending
NCI E-115-2015-0-US-03 HYPOXIA INDUCIBLE FACTOR 1 (HIF-1) INHIBITORS US National Stage 15/563,851 10246463 Issued PDF
NLM E-107-2010-2-US-16 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 15/722,202 Abandoned
NLM E-107-2010-2-US-17 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 15/722,183 Abandoned
NHLBI E-222-2022-1-US-01 Catheters and Manipulators with Deflectable Ends US 62/567,203 Expired
NIAID E-233-2017-0-US-01 ASSAY FOR THE DETECTION OF ALPHA-SYNUCLEIN SEEDING ACTIVITY ASSOCIATED WITH SYNUCLEINOPATHIES US 62/567,079 Abandoned
NCI E-173-2015-0-EP-08 Module For Freezing And Storage Of Frozen Tissue EP DIV 22169969.7 Issued
NCI E-173-2015-0-GB-01 FROZEN TISSUE SPECIMEN STORAGE KIT GB EP 22169969.7 Issued
NCI E-173-2015-0-FR-01 FROZEN TISSUE SPECIMEN STORAGE KIT FR EP 22169969.7 Issued
NCI E-173-2015-0-DE-01 FROZEN TISSUE SPECIMEN STORAGE KIT DE EP 22169969.7 Issued
NCI E-173-2015-0-DE-05 Module For Freezing And Storage Of Frozen Tissue DE EP 17785103.7 Issued
NCI E-173-2015-0-FR-06 Module For Freezing And Storage Of Frozen Tissue FR EP 17785103.7 Issued
NCI E-173-2015-0-GB-07 Module For Freezing And Storage Of Frozen Tissue GB EP 17785103.7 Issued
NCI E-173-2015-0-EP-03 Module For Freezing And Storage Of Frozen Tissue EP National Stage 17785103.7 Issued
NCI E-173-2015-0-PCT-02 Module For Freezing And Storage Of Frozen Tissue PCT PCT PCT/US2017/054531 Expired
NHLBI E-207-2016-0-PCT-02 METHOD FOR FUNCTIONALIZING CARBON NANOPARTICLES AND COMPOSITIONS PCT PCT PCT/US2017/054351 Expired
NHGRI E-090-2015-0-US-04 TAGGED FORM OF MUT ENZYME, GENETIC CONSTRUCTS INCORPORATING IT, AND ITS USE IN GENE THEREAPY US National Stage 15/563,379 Abandoned
NHLBI E-196-2017-0-US-01 POLYDOPAMINE-ENCAPSULATED NANODIAMONDS AND METHODS US 62/565,552 Abandoned
NCI E-237-2017-0-US-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 US 62/565,383 Abandoned
NCI E-237-2017-1-US-01 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION US 62/565,464 Abandoned
NCI E-289-2011-0-MX-19 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF MX DIV MX/a/2017/012601 Pending
NIAID E-065-2018-0-EP-06 COMPOSITIONS COMPRISING PREGNANCY SPECIFIC GLYCOPROTEINS AND METHODS OF USE THEREOF EP National Stage 16847381.7 Issued
NCI E-176-2014-0-HK-14 Anti-Human Papillomavirus 16 E7 T Cell Receptors HK EP 17109823.5 Issued
NCI E-062-2019-3-PCT-01 METHOD OF TREATING UROTHELIAL CARCINOMA AND OTHER GENITOURINARY MALIGNANCIES USING N-(4-(6,7-DIMETHOXYQUINOLIN-4-YLOXY)PHENYL)-N'-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE PCT PCT COMB PCT/US2017/053766 Expired
NCI E-062-2019-3-HK-09 METHOD OF TREATING UROTHELIAL CARCINOMA AND OTHER GENITOURINARY MALIGNANCIES USING N-(4-(6,7-DIMETHOXYQUINOLIN-4-YLOXY)-PHENYL)-N'-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE HK EP 62020002296.5 Pending
NIAID E-065-2018-0-JP-04 COMPOSITIONS COMPRISING PREGNANCY SPECIFIC GLYCOPROTEINS AND METHODS OF USE THEREOF JP National Stage 2017-551585 Abandoned
NCI E-062-2019-3-CA-03 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide CA National Stage 3038500 Abandoned
NIAID E-065-2018-0-US-03 COMPOSITIONS COMPRISING PREGNANCY SPECIFIC GLYCOPROTEINS AND METHODS OF USE THEREOF US National Stage 15/561,622 11007249 Issued PDF
NHLBI E-211-2018-3-US-01 Methods Of Inhibiting Viruses Using Compositions Targeting TSG101-Ubiquitin Interaction US 62/563,495 Abandoned
NIAID E-065-2018-0-AU-07 COMPOSITIONS COMPRISING PREGNANCY SPECIFIC GLYCOPROTEINS AND METHODS OF USE THEREOF AU National Stage 2016323769 Issued
NCI E-025-2015-0-US-03 ANTI-CD133 MONOCLONAL ANTIBODIES AND RELATED COMPOSITIONS AND
METHODS 		US National Stage 15/561,403 10711068 Issued PDF
NCI E-086-2015-0-US-04 BISPECIFIC MULTIVALENT FUSION PROTEINS US National Stage 15/561,268 10472412 Issued PDF
NIAID E-239-2014-0-KR-04 MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE KR National Stage 10-2017-7027105 Abandoned
NIAID E-297-2016-2-IN-04 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES IN National Stage 201917015489 Issued
NIAID E-297-2016-2-PCT-01 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES PCT PCT COMB PCT/US2017/053047 Expired
NCI E-258-2016-0-AU-03 CHIMERIC ANTIGEN RECEPTOR (CAR) THAT TARGETS CHEMOKINE RECEPTOR CCR4 AND ITS USE AU National Stage 2017332161 Issued
NCI E-258-2016-0-DE-01 CHIMERIC ANTIGEN RECEPTOR (CAR) THAT TARGETS CHEMOKINE RECEPTOR CCR4 AND ITS USE DE EP 17778069.9 Issued
NCI E-258-2016-0-FR-01 CHIMERIC ANTIGEN RECEPTOR (CAR) THAT TARGETS CHEMOKINE RECEPTOR CCR4 AND ITS USE FR EP 17778069.9 Issued
NCI E-258-2016-0-EP-05 CHIMERIC ANTIGEN RECEPTOR (CAR) THAT TARGETS CHEMOKINE RECEPTOR CCR4 AND ITS USE EP National Stage 17778069.9 Abandoned
NCI E-258-2016-0-GB-01 CHIMERIC ANTIGEN RECEPTOR (CAR) THAT TARGETS CHEMOKINE RECEPTOR CCR4 AND ITS USE GB EP 17778069.9 Issued
NCI E-162-2014-0-HK-07 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE HK CN 17109560.2 Issued